Provided by Tiger Trade Technology Pte. Ltd.

Progress

44.17
+1.282.98%
Volume:138.88K
Turnover:6.09M
Market Cap:1.86B
PE:26.61
High:44.20
Open:43.10
Low:43.10
Close:42.89
52wk High:65.50
52wk Low:38.54
Shares:42.11M
Float Shares:42.11M
Volume Ratio:0.50
T/O Rate:0.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.66
EPS(LYR):1.66
ROE:15.95%
ROA:4.38%
PB:3.89
PE(LYR):26.61

Loading ...

Balanced Risk/Reward Keeps Aimia Inc. at Hold Despite Operational Progress

TIPRANKS
·
12 mins ago

Why Enphase Energy (ENPH) Is Up 34.9% After Q4 Earnings, EV Platform Progress And Buybacks

Simply Wall St.
·
Yesterday

Assessing ITT (ITT) Valuation After Q4 Beat Dividend Hike And SPX FLOW Acquisition Progress

Simply Wall St.
·
Yesterday

Onto Innovation (ONTO) Is Up 5.8% After TSMC Tool Progress And Semilab Deal - Has The Bull Case Changed?

Simply Wall St.
·
Yesterday

Minerals 260's Bullabulling Gold Project Shows Strong Progress, Says Euroz Hartleys

MT Newswires Live
·
Yesterday

Waterco Updates Market on Progress of On-Market Share Buy-Back

TIPRANKS
·
Yesterday

Ferrari Details Progress on €3.5 Billion Multi-Year Share Buyback as Treasury Stake Nears 9%

TIPRANKS
·
Yesterday

Plus500 Performance Shows Progress -- Market Talk

Dow Jones
·
Feb 09

Atlas Metals Flags Rising Value and Legal Progress at Kyrgyz Uranium Project

TIPRANKS
·
Feb 09

Taki Chemical Details 2025 Results and Progress on Medium-Term Plan 2028

TIPRANKS
·
Feb 09

Dyno Nobel Updates ASX on Progress of On‑Market Share Buy‑Back

TIPRANKS
·
Feb 09

MAAS Group Updates ASX on Progress of On-Market Share Buy-Back

TIPRANKS
·
Feb 09

Orica Updates Market on Progress of Ongoing On‑Market Share Buy‑Back

TIPRANKS
·
Feb 09

HII Carrier Trials Progress Highlight Long Cycle Growth And Budget Watchpoints

Simply Wall St.
·
Feb 09

Under Armour: Early Turnaround Progress Offset by Persistent Margin Headwinds, Justifying Hold Rating

TIPRANKS
·
Feb 09

Viasat Earnings Call: Progress Amid Transitional Headwinds

TIPRANKS
·
Feb 08

Under Armour Earnings Call: Progress Amid Persistent Strains

TIPRANKS
·
Feb 07

Regis Corporation Earnings Call: Progress Amid Persistent Headwinds

TIPRANKS
·
Feb 07

Ultragenyx: UX111 Progress, Regulatory De-Risking, and Pipeline Catalysts Support Attractive Risk/Reward and Buy Rating

TIPRANKS
·
Feb 07

Regeneron’s REGN9533 Trial Completion Signals Quiet but Important Progress in Clot-Blocking Drugs

TIPRANKS
·
Feb 07